Progress in aorta and peripheral cardiovascular disease research

Abstract Although coronavirus disease 2019 seems to be the leading topic in research number of outstanding studies have been published field aorta and peripheral vascular diseases likely affecting our clinical practice near future. This review article highlights key on 2020. Some shed light pathophysiology aortic aneurysm dissection suggesting a potential role for kinase inhibitors as new therapeutic options. A first proteogenomic study fibromuscular dysplasia (FMD) revealed promising novel gene provided proof-of-concept protein/lipid-based FMD blood test. The NADPH oxidases physiology, particularly endothelial cell differentiation, is highlighted with therapy development. Imaging vulnerable plaque has an intense research. Features vulnerability magnetic resonance imaging under-recognized cause stroke are discussed. Major trials lower extremity artery shown added benefit dual antithrombotic (aspirin plus rivaroxaban) treatment.